Wendell et al v. Johnson & Johnson et al

Filing 176

ORDER Granting 175 Stipulation FOR ORDER EXTENDING TIME. Signed by Judge Claudia Wilken on 6/23/2011. (ndr, COURT STAFF) (Filed on 6/23/2011)

Download PDF
1 3 Kevin Haverty, Esq., pro hac vice WILLIAMS CUKER BEREZOFSKY, LLC 210 Lake Drive East, Suite 101 Cherry Hill, NJ 08002 Telephone: (856) 667-0500 4 Attorneys for Plaintiffs 2 5 6 7 8 UNITED STATES DISTRICT COURT 9 NORTHERN DISTRICT OF CALIFORNIA 10 OAKLAND DIVISION 11 12 13 STEPHEN WENDELL AND LISA WENDELL, for themselves and as successors in interest to MAXX WENDELL, DECEASED, 14 15 16 17 18 19 20 CASE NO. 4:09-CV-04124-CW STIPULATED REQUEST FOR ORDER EXTENDING TIME AND ORDER Plaintiffs, v. JOHNSON & JOHNSON; CENTOCOR, INC.; ABBOTT LABORATORIES; SMITHKLINE BEECHAM d/b/a GLAXOSMITHKLINE; TEVA PHARMACEUTICALS USA; GATE PHARMACEUTICALS, a division of TEVA PHARMACEUTICALS USA; PAR PHARMACEUTICAL, INC.; Removal Filed: September 4, 2009 Defendants. 21 22 23 24 25 26 27 28 STIPULATED REQUEST FOR ORDER EXTENDING TIME AND [PROPOSED] ORDER CASE NO. 4:09-CV-04124-CW 1 STIPULATION 2 3 4 Pursuant to Rule 6-2(a), the parties jointly request that the deadlines be extended as set forth herein. On September 4, 2009, this case was removed to the United States District Court for the 5 Northern District of California. A series of motions resolved multiple pleadings issues at the outset 6 of this litigation. On June 10, 2010 plaintiffs filed the operative amended Complaint and the 7 defendants all filed Answers on July 1, 2010. Discovery beyond initial disclosures began once 8 pleadings issues were resolved. 9 10 In the interim, the court, on June 3, 2010, entered a Case Management Order which provided, among other things, that fact discovery was to end on February 2, 2011. 11 On July 13, 2010, plaintiffs served interrogatories and requests for production of documents 12 on all defendants. Defendants served responses to those discovery requests variously on August 25, 13 2010 (Centocor), September 24, 2010 (Par Pharmaceutical and Teva), October 4, 2010 (Abbott 14 Laboratories) and November 15, 2010 (GlaxoSmithKline). Defendants indicated that responsive 15 documents would be provided or made available for inspection and copying subject to the entry of a 16 protective order. 17 On July 28, 2010, plaintiffs’ counsel sent an email to counsel for defendant Abbott 18 Laboratories asking her to identify 30(b)(6) witnesses for deposition, Exhibit 1, to which she 19 responded the next day that Abbott would endeavor to identify the appropriate witnesses. Exhibit 2. 20 In Abbott’s responses to plaintiffs’ discovery requests, various witnesses with knowledge are 21 identified but Plaintiffs state that their depositions cannot be properly conducted until the underlying 22 documents have been reviewed. 23 On or about December 20, 2010, the Court granted the parties’ request to extend the deadline 24 to conduct mediation to June 29, 2011. On or about February 3, 2011, the Court granted the parties’ 25 request to extend the discovery end date until June 30, 2011, and ordered that Plaintiffs designate 26 testifying experts and provide related reports by August 12, 2011, Defendants designate testifying 27 experts and provide related reports by October 30, 2012 [sic], the parties complete expert discovery 28 1 STIPULATED REQUEST FOR ORDER EXTENDING TIME AND [PROPOSED] ORDER CASE NO. 4:09-CV-04124-CW 1 on or before December 14, 2011, and dispositive motions be heard on or before (and a case 2 management conference would be set for) January 26, 2012. The trial date was not continued. 3 A protective order was ultimately entered by the Court on April 19, 2011. Thereafter, 4 Defendants collectively produced millions of pages of documents on disk drives to Plaintiffs. These 5 productions occurred variously on April 19 (Centocor) and May 11, 18 and 24, 2011 (Abbott). 6 Defendants GlaxoSmithKline, Teva and Par have offered to make documents available for 7 inspection and copying in response to Plaintiffs’ requests. Defendant Centocor has offered to make 8 available for inspection and copying its hard-copy production. 9 The parties have completed key depositions in this litigation, such as the deposition of Maxx 10 Wendell’s prescribing physician on April 11, 2011, and of Plaintiffs and another family member on 11 June 14, 2011. On several occasions, the last of which occurred on June 16, 2011, the parties 12 conferred about issues related to timing of mediation, potential dispositive motion practice, and 13 further discovery. 14 The parties have agreed to mediate this case with Honorable Rebecca Westerfield. The 15 parties are attempting to identify a mutually agreeable date in August but will, in any event, schedule 16 the mediation to occur on or before September 15, 2011. The parties believe that a stay of 17 discovery until after the mediation or, if the mediation is unsuccessful, until after the ruling on the 18 motions for summary judgment discussed below, will allow the parties to conserve resources for 19 settlement, conserve judicial resources, and help resolve the litigation. 20 Defendants plan to file motions for summary judgment based on the learned intermediary 21 doctrine. Defendants do not need additional discovery to file such motions. Plaintiffs have 22 conducted all discovery needed to oppose such motions and do not plan to oppose the motion on the 23 grounds that further discovery is necessary. 24 Should those motions and the mediation be unsuccessful, some additional fact discovery 25 would need to be conducted by the parties. Plaintiffs would need to conduct additional discovery 26 bearing on the issues of the adequacy of the warning labels which will not only involve reviewing 27 and selecting pertinent documents from the electronic discovery provided by Defendants but also 28 2 STIPULATED REQUEST FOR ORDER EXTENDING TIME AND [PROPOSED] ORDER CASE NO. 4:09-CV-04124-CW 1 conduct depositions pursuant to Fed. R. Civ. P. 30(b)(6). If they have not already done so, Plaintiffs 2 will supplement their responses to Defendants’ written discovery requests by providing (1) a list of 3 the categories of damages they seek and amounts for each and (2) certain responsive documents 4 Plaintiffs testified were available but which have not yet been produced to Defendants. Further fact 5 discovery to be conducted by Defendants includes taking additional depositions of at least two of 6 Maxx Wendell’s treating oncologists1 and any discovery arising from Plaintiffs’ responses to written 7 discovery previously propounded by Defendants. 8 THE PARTIES HEREBY STIPULATE AS FOLLOWS: 9 1. 10 The parties hereto request that the June 29, 2011 deadline for the parties to conduct private mediation be continued to September 15, 2011. 11 2. The parties request that all other deadlines be vacated. 12 3. The parties request that discovery be stayed until after the mediation or ruling on 13 defendants’ motions for summary judgment, whichever comes later; at that time the parties will meet 14 and confer to determine a proposed schedule for remaining fact discovery listed above, expert 15 discovery, other pre-trial deadlines, and a new trial date. 16 4. The parties will file a proposed scheduling order within two weeks of the mediation 17 (in the event it is unsuccessful) or ruling on defendants’ motions for summary judgment, whichever 18 comes later. 19 // 20 // 21 // 22 // 23 // 24 // 25 // 26 // 27 28 1 These depositions were previously scheduled for June 24, 2011. The parties would like to continue these depositions to after the mediation to avoid incurring potentially unnecessary costs. 3 STIPULATED REQUEST FOR ORDER EXTENDING TIME AND [PROPOSED] ORDER CASE NO. 4:09-CV-04124-CW 1 5. DECLARATION PURSUANT TO L.R. 6-2(a): The parties declare that (1) the 2 reason for the requested enlargement of time is to allow the parties to engage in mediation, potential 3 early dispositive motion practice and additional discovery should mediation or motion practice fail 4 to dispose of the case; (2) as set forth above, the parties anticipate that this modification of the 5 discovery end date will affect other deadlines including the April 2012 trial date. 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 DATED: June 22, 2011 /s/ Kevin Haverty Kevin Haverty (pro hac vice) WILLIAMS CUKER BEREZOFSKY, LLC Woodland Falls Corporate Park 210 Lake Drive East, Suite 101 Cherry Hill, NJ 08002 Counsel for Plaintiffs /s/ Andrew P. Bautista Andrew P. Bautista (pro hac vice) KIRKLAND & ELLIS LLP 300 North LaSalle Chicago, Illinois 60654 Counsel for Abbott Laboratories /s/ Michelle A. Childers Michelle A. Childers DRINKER BIDDLE & REATH LLP 50 Freemont Street, 30th Fl. San Francisco, CA 94105 Counsel for Centocor Ortho Biotech, Inc. and Johnson & Johnson /s/ Prentiss W. Hallenbeck, Jr. Prentiss W. Hallenbeck, Jr. (pro hac vice) ULMER & BERNE LLP 600 Vine Street, Suite 2800 Cincinnati, OH 45202 Counsel for Teva Pharmaceuticals USA, Inc. /s/ William A. Hanssen William A. Hanssen DRINKER BIDDLE & REATH LLP 333 South Grand Ave., Ste. 1700 Los Angeles, CA 90071-1504 Counsel for SmithKline Beecham Corporation d/b/a GlaxoSmithKline /s/ Prentiss W. Hallenbeck, Jr. Prentiss W. Hallenbeck, Jr. (pro hac vice) ULMER & BERNE LLP 600 Vine Street, Suite 2800 Cincinnati, OH 45202 Counsel for Par Pharmaceutical, Inc. 22 PURSUANT TO STIPULATION, IT IS SO ORDERED. Defendants shall notice their motion on the learned intermediary defense for not later than Jan. 26, 2012, and a case management conference will be held on that date at 2 pm. 23 June 23 Dated: _________________, 2011 24 CLAUDIA WILKEN United States District Judge 25 26 27 28 4 STIPULATED REQUEST FOR ORDER EXTENDING TIME AND [PROPOSED] ORDER CASE NO. 4:09-CV-04124-CW 1 ATTESTATION PURSUANT TO GENERAL ORDER 45 2 I, Kevin Haverty, am the ECF user whose ID and password are being used to file this 3 STIPULATED REQUEST FOR ORDER EXTENDING TIME AND [PROPOSED] ORDER. In 4 compliance with General Order 45, X.B., I hereby attest that the following attorneys have concurred 5 in this filing: Andrew P. Bautista, counsel for Abbott Laboratories; Michelle A. Childers, counsel 6 for Centocor Ortho Biotech, Inc., and Johnson & Johnson; Prentiss W. Hallenbeck, Jr., counsel for 7 Teva Pharmaceuticals USA, Inc., and Par Pharmaceutical, Inc.; William A. Hanssen, counsel for 8 SmithKline Beecham Corporation. /s/ Kevin Haverty 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 5 STIPULATED REQUEST FOR ORDER EXTENDING TIME AND [PROPOSED] ORDER CASE NO. 4:09-CV-04124-CW 1 2 CERTIFICATE OF SERVICE I HEREBY CERTIFY that on June 22, 2011, I electronically filed the foregoing 3 STIPULATED REQUEST FOR ORDER EXTENDING TIME AND [PROPOSED] ORDER with 4 the Clerk of the Court using the CM/ECF system which will send notification of such filing to the 5 email addresses registered, as denoted on the Court’s Electronic Mail Notice List, and I hereby 6 certify that I have mailed a true and correct copy of the foregoing document via the United States 7 Postal Service to the non-CM/ECF participants listed below: 8 9 10 John D. Winter Patterson, Belknap, Webb & Tyler LLP 1133 Avenue Of The Americas New York, New York 10036-6710 Jeffrey F. Peck Ulmer & Berne LLP 600 Vine Street, Suite 2800 Cincinnati, Ohio 45202 11 12 I declare under penalty of perjury under the laws of the United States that the foregoing is true and 13 correct. 14 DATED: June 22, 2011 15 By: s/ Kevin Haverty 16 Kevin Haverty, pro hac vice WILLIAMS CUKER BEREZOFSKY, LLc Khaverty@wcblegal.com 210 Lake Drive East, Suite 101 Cherry Hill, New Jersey 08002 Telephone: (856) 667-0500 Fax: (856) 667-5133 17 18 19 20 21 22 23 24 25 26 27 28 1 CERTIFICATE OF SERVICE CASE NO. 4:09-CV-04124-CW

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?